首页|基于PI3K/Akt/mTOR信号通路探讨中医药防治乳腺癌的研究进展

基于PI3K/Akt/mTOR信号通路探讨中医药防治乳腺癌的研究进展

Research Progress on the Intervention of Traditional Chinese Medicine on the Prevention and Treatment of Breast Cancer via PI3K/Akt/mTOR Signaling Pathway

扫码查看
磷脂酰肌醇3-蛋白激酶B-哺乳动物雷帕霉素靶蛋白(PI3K/Akt/mTOR)信号传导通路在癌症细胞的增殖、凋亡、分化、侵袭等方面具有重要的调节作用,参与了乳腺癌的发生发展过程,是治疗乳腺癌的重要靶点.文章从PI3K/Akt/mTOR信号通路及靶向药物,PI3K/Akt/mTOR信号通路通过促进血管内皮因子生成、促进细胞增殖、抑制细胞凋亡和促进炎症因子分泌来影响乳腺癌发生发展的机制,中药通过该通路对乳腺癌细胞的增殖、凋亡及耐药的干预作用三个方面进行综述,以期为乳腺癌的治疗药物研发提供参考.
As an important target for the treatment of breast cancer,the phosphatidylinositol-3 kinase(PI3K)/protein kinase B(Akt)/mammalian target of rapamycin(mTOR)signaling pathway can regulate cell proliferation,apoptosis,differentiation and invasion of cancer cells,participating in the occurrence and development of breast cancer.This article reviews the PI3K/Akt/mTOR signaling pathway and targeted drugs,the occurrence and development of breast cancer influnenced by promoting the production of vascular endothelial factor,enhancing cellular proliferation,inhibiting cellular apoptosis and promoting the secretion of inflammatory factors mediated by the signaling pathway,as well as TCM intervention on the proliferation,apoptosis and drug resistance of breast cancer cells via the signaling pathway,and it is designed to provide the reference for the research and development of therapeutic medicine for breast cancer.

PI3K/Akt/mTOR signaling pathwaybreast cancerTCMresearch progress

郑珮怡、张馨月、李思雨、薛晓红

展开 >

上海中医药大学附属岳阳中西医结合医院,上海 200437

上海市松江区方塔中医医院,上海 201699

PI3K/Akt/mTOR通路 乳腺癌 中医药 研究进展

上海市科学技术委员会2020年度"科技创新行动计划"医学创新研究专项促进市级医院临床技能与临床创新能力三年行动计划项目上海市中医优势病种培育项目岳阳医院院级课题青年孵育项目

20Y21901100SHDC2020CR4057zybz-20170082019YYQ24

2024

西部中医药
甘肃中医药研究院

西部中医药

CSTPCD
影响因子:0.98
ISSN:1004-6852
年,卷(期):2024.37(2)
  • 1
  • 15